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BACKGROUND Despite clinical trial evidence supporting the efﬁcacy
of transcatheter aortic valve replacement (TAVR), questions remain
regarding outcomes of TAVR among very elderly patients, who are
often considered high risk simply due to age. Little is known about the
outcomes of nonagenarians undergoing TAVR in current clinical
practice.
METHODS National U.S. data from the Society of Thoracic Surgeons/
American College of Cardiology Transcatheter Valve Therapy (STS/
ACC TVT) Registry was evaluated. Outcomes at 30-days and 1-year
were compared between patients 90 vs <90 years of age using cu-
mulative incidence curves. For non-fatal outcomes, including stroke,
heart failure readmission, aortic valve reintervention and post-
procedural myocardial infarction, death was considered a competing
risk.
RESULTS Between November 2011 - September 2014, 24,025 patients
underwent TAVR in 329 participating hospitals, of which 3773 (15.7%)
were age 90. Nonagenarians (vs <90) had slower ﬁve meter walk
tests (8.7 sec vs 8.0 sec), higher STS Predicted Risk of Mortality Score
(9.2% vs 6.3%) and yet reported better health status prior to TAVR
(KCCQ-OS scores: 41.7 vs 37.5). The 30-day (8.8% vs 5.9%) and 1-year
(24.8% vs 22.0%) mortality was signiﬁcantly higher among
patients 90 years old (see Figure 1; absolute risk 2.8%, relative risk
12.7%). There was also a higher rate of heart failure readmission after
30 days (5.3% vs 4.3%) but not after 1 year (14.9% vs 14.5%). No dif-
ferences in stroke rate, aortic valve reintervention or myocardial
infarction were seen after 30 days or 1 year.CONCLUSIONS In current U.S. clinical practice, approximately 16% of
TAVR patients are 90 years of age. Although 30-day and 1-year
mortality was statistically higher compared with younger TAVR pa-
tients, the absolute and relative differences were clinically modest.
These data support safety and efﬁcacy of TAVR in selected older
patients.
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BACKGROUND Accurate assessment of cardiac output (CO) is essen-
tial for the hemodynamic assessment of cardiac patients and espe-
cially in the setting of valve disease. Estimation of oxygen
consumption (VO2) is employed in many cardiac catheterization lab-
oratories given the historically cumbersome nature of direct VO2
measurement, the “gold standard” for this technique. Thermodilution
(TD) is used instead of assumed VO2 in many labs as well. We
compared direct VO2 CO and aortic valve area (AVA) to those based on
assumed VO2 and TD in patients with suspected aortic stenosis.
METHODS Thirty consecutive patients undergoing right heart cathe-
terization had simultaneous determination of CO by both direct and
assumed VO2 and TD. A portable facemask device allowed the direct
measurement of VO2. All measurements of direct and assumed VO2,
as well as, TD CO were obtained in triplicate.
RESULTS Directly measured VO2 CO and estimated VO2 CO calcu-
lations correlated poorly (R¼ 0.57; ICC ¼0.59). Directly measured
VO2 CO and thermodilution CO calculations correlated poorly, as
well (R¼ 0.51; ICC ¼0.60). Furthermore, when the CO from these
different methods of VO2 measurement was utilized to calculate
aortic valve areas, those areas derived from directly measured and
estimated VO2 values correlated poorly as well (R¼ 0.68; ICC ¼0.55).
Similarly, the correlation between AVA, in those patients in whom it
was the focus of the catheterization, based on direct VO2 and TD was
poor (R¼ 0.66; ICC ¼0.60). Using a constant assumed VO2 value led
to a large discrepancy in repeated CO measurement during the case
(R¼ 0.62; ICC ¼0.57). Repeated TD CO was associated with less
discrepancy (R¼ 0.78; ICC ¼0.84). Although directly measured VO2
